Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)

Federal funding opportunity PAR-27-055 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes May 25, 2029

Program funding history

Synopsis

Who can apply

• Public housing authorities/Indian housing authorities
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• County governments
• Small businesses
• State governments
• Special district governments
• Independent school districts
• Private institutions of higher education
• For profit organizations other than small businesses
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Native American tribal governments (Federally recognized)
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Public and State controlled institutions of higher education
• Native American tribal organizations (other than Federally recognized tribal governments)
• City or township governments

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Eligibility is restricted to institutions that meet all the following criteria: In an IDeA-eligible state, commonwealth, or jurisdiction, which are Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming; andAward doctoral degrees in health-related sciences or are independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by the NIH or other federal agencies; andHold three or fewer active COBRE awards (except for COBRE Phase 3), including those in no-cost extension at the time of application submission. Applications will not be accepted from organizations that hold four or more active Phase 1, Phase 2, COBRE-D, COBRE-E, and COBRE-S awards, including those in no-cost extension. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

How to apply

Similar grants

• Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)
  PAR-27-054 · National Institutes of Health · closes May 26, 2029
• Limited Competition: Biomedical Research Environment & Sponsored Programs Administration Development (BRE-SPAD) Program
  PAR-29-004 · National Institutes of Health
• Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)
  PAR-27-056 · National Institutes of Health · closes May 30, 2029
• Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
  RFA-OD-27-009 · National Institutes of Health · closes November 10, 2026
• IDeA Networks of Biomedical Research Excellence (INBRE)
  PAR-26-026 · National Institutes of Health
• Limited Competition: Tribal Undergraduate and Graduate Research Training and Leadership Experiences (TURTLE) Program
  PAR-28-050 · National Institutes of Health